Daxor Corporation
DXR Healthcare Medical Instruments & Supplies
Revenue growth for five consecutive years.
Follow DXR
Daxor Corporation (DXR) EV/Sales
As of 16 October 2026, Daxor Corporation (DXR) trades at a EV/Sales of −14.4×. Over the past ten years it has ranged from −317× (July 2020) to 141× (April 2020); the current reading is higher than 33% of that period. That is below the Medical Instruments & Supplies industry median of 2.9× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2022 | −13.5× | — |
| FY2021 | −9.4× | — |
| FY2020 | −49.3× | — |
| FY2019 | 85.3× | — |
| FY2018 | −58.9× | — |
| FY2017 | −4.8× | — |
| FY2016 | 7.1× | 58.92% |
| FY2015 | 4.5× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2023 | −13.8× | — |
| Dec 2022 | −13.5× | — |
| Jun 2022 | −14.1× | — |
| Dec 2021 | −9.4× | — |
| 7 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| DXR Daxor Corporation | −14.4× |
| MBOT Microbot Medical Inc. compare | −2.9× |
| NYXH Nyxoah SA compare | 0.7× |
| POCI Precision Optics Corp. compare | 0.9× |
| HBIO Harvard Bioscience, Inc. compare | 1.1× |
| NEPH Nephros Inc. compare | 1.7× |
| MLSS Milestone Scientific, Inc. compare | 3.1× |
| STXS Stereotaxis Inc. compare | 3.1× |
| ZTEKF Zentek Ltd. compare | 288× |
| Medical Instruments & Supplies industry median | 2.9× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)